OXNARD GEOFFREY RAYMOND enters BLOSSOMHILL THERAPEUTICS, INC. with 17.79K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/7/2026ACC: 0002144320-26-000002
Officer· Chief Medical Officer
Since Aug 2026
17.79K
Baseline shares
100% direct
17.79K
Direct ownership
1 position
186.40K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned17.79K
Total
17.79K direct17.79K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 17.79K | Direct |
| Total | 17.79K | 17.79K direct |
Derivative Holdings2
Employee Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
152.37K
Shares owned
N/A
Exercise price
5.63
Expiration
—
Exercise window
—
Employee Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
34.03K
Shares owned
N/A
Exercise price
6.28
Expiration
—
Exercise window
—
Total
Underlying
186.40K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock | 5.63 | — | — | 152.37K | N/A |
| Employee Stock Option (Right to Buy) Direct | Common Stock | 6.28 | — | — | 34.03K | N/A |
| Total | 186.40K | 0.00 | ||||